-
Comprehensive ALS Genomic Landscape-Implications for Drug Discovery/Development
Hi All,
Came across this youtube video from Genomenon, that discusses Genomenon’s comprehensive genomic landscape of ALS-associated genes and its implications for drug discovery and development. Would like to hear any thoughts on this presentation.
https://www.youtube.com/watch?v=8hxxll88Qn8
Presentation Information
In this presentation, Genomenon Founder and Chief Science Officer, Dr. Mark Kiel presents the most comprehensive genomic landscape of 36+ ALS-associated genes and a complete characterization of all disease-causing variants, assessed to clinical standards and annotated for actionability. Additionally, Dr. Kiel discusses the results of this curation effort and what it may mean for improving ALS diagnosis and treatment.
Company Information
Genomenon is a genomic health IT company that keeps pace with the constant advancements made in genomics and connects that research to patient DNA to help diagnose and treat patients with rare genetic diseases.
Richard
-
0 Replies
-
Hi Richard!
I’m Candace from Genomenon and I’m glad you found our webinar. Since then, we have gone much further in our work to support ALS research and drug development. Last week, we released news about it: https://www.genomenon.com/genomenon-publishes-key-findings-from-genomic-landscape-for-als/
and a new report on the data: https://www.genomenon.com/als-report/
I hope it is encouraging to you and the community!
Candace
Log in to reply.